How these volunteers are helping poor patients find beds at hospitals

NEW DELHI: There are over 650 beds reserved for the poor in private hospitals that have got land on concessional rates in Delhi. But nearly 150 of them are always vacant. Apart from government officials and a court-appointed committee, some social activists have come forward to maximise the utilisation of the facility of free beds for the economically weaker sections. One of them, charitybeds.com, is run by former president of The Oberoi Group, Kapil Chopra.

Chopra told TOI that they update their website daily as per the list of vacant beds provided to them through the government website or private hospitals. “I have a few volunteers also. Their numbers are available on the website. We get more than 200 calls daily, seeking info on vacant beds, documents needed for admission, and in some cases, help to get admission,” Chopra said.

How these volunteers are helping poor patients find beds at hospitals

There are more than 50 hospitals in Delhi that were given land on concessional rates by Delhi Development Authority after the management of the hospitals promised free treatment to poor patients. But as they didn’t honour the commitment, Delhi-based NGO Social Jurist filed a PIL in Delhi high court for implementation of the agreement.

The high court, in a series of orders since 2002, held that the hospitals were obliged to reserve 25% of OPD and 10% of IPD for poor patients and provide free treatment, including admission, bed, medication, consumables and non-consumables. The court, however, exempted some hospitals in 2014 whose agreement with the government authorities didn’t have the provision to provide free treatment. On Monday, the Supreme Court reiterated hospitals that got land on concessional rates would have to provide free treatment to the EWS with 25% of OPD and 10% of IPD reserved.

Gagan, a volunteer with charitybeds.com, said that often the poor aren’t aware of the law or their rights. “They are too intimidated to go to a luxury hospital and demand admission. Sometimes the hospitals refuse admission on grounds like unavailability of ICU facility or beds under the desired specialty. We try to intervene in such circumstances and find the right place for admission under EWS category,” he said.

Ashok Agarwal, eminent lawyer and activist who has been spearheading efforts to implement EWS policy, said occupancy rates have gone up significantly over the last few years.

  • Related Posts

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi:  Patient safety in hospitals is a global concern, more so in India. It…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    US market to dent India pharma earnings even as domestic growth remains firm

    US market to dent India pharma earnings even as domestic growth remains firm

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg